1. "Reversi‐type virologic failure" involved in the development of non‐structural protein 5A resistance‐associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline. Issue 13 (19th April 2017) Authors: Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Inao, Mie; Imai, Yukinori; Nakayama, Nobuaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 47:Issue 13(2017) Page Start: 1397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A case of genotype‐3b hepatitis C virus in which the whole genome was successfully analyzed using third‐generation nanopore sequencing. Issue 9 (13th June 2019) Authors: Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Uemura, Hayato; Tsuji, Shohei; Sugawara, Kayoko; Nakao, Masamitsu; Motoya, Daisuke; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 49:Issue 9(2019) Page Start: 1083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multicenter pilot survey to clarify the clinical features of patients with acute‐on‐chronic liver failure in Japan. Issue 4 (2nd March 2018) Authors: Nakayama, Nobuaki; Uemura, Hayato; Uchida, Yoshihito; Tomiya, Tomoaki; Ido, Akio; Inoue, Kazuaki; Genda, Takuya; Takikawa, Yasuhiro; Sakaida, Isao; Terai, Shuji; Yokosuka, Osamu; Shimizu, Masahito; Takikawa, Hajime; Mochida, Satoshi Journal: Hepatology research Issue: Volume 48:Issue 4(2018) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct‐acting antivirals. Issue 3 (25th September 2017) Authors: Kurata, Hayato; Uchida, Yoshihito; Kouyama, Jun‐Ichi; Naiki, Kayoko; Nakazawa, Manabu; Ando, Satsuki; Nakao, Masamitsu; Motoya, Daisuke; Sugawara, Kayoko; Inao, Mie; Imai, Yukinori; Nakayama, Nobuaki; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 48:Issue 3(2018) Page Start: E372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Deteriorated outcome of recent patients with acute liver failure and late‐onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan. Issue 8 (29th May 2019) Authors: Nakao, Masamitsu; Nakayama, Nobuaki; Uchida, Yoshihito; Tomiya, Tomoaki; Oketani, Makoto; Ido, Akio; Tsubouchi, Hirohito; Takikawa, Hajime; Mochida, Satoshi Journal: Hepatology research Issue: Volume 49:Issue 8(2019) Page Start: 844 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Development of rare resistance‐associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two‐hit mechanism. Issue 12 (30th March 2016) Authors: Uchida, Yoshihito; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Inao, Mie; Imai, Yukinori; Nakayama, Nobuaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 46:Issue 12(2016) Page Start: 1234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Drug‐induced immunoallergic hepatitis during combination therapy with daclatasvir and asunaprevir. Issue 1 (15th December 2014) Authors: Fujii, Yohei; Uchida, Yoshihito; Mochida, Satoshi Journal: Hepatology Issue: Volume 61:Issue 1(2015:Jan.) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa® SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2. Issue 6 (June 2023) Authors: Kodana, Masahiro; Orihara, Yuta; Tezuka, Mariko; Takahashi, Rina; Noguchi, Sakiko; Matsuzaki, Nanako; Takada, Tomohito; Kobari, Naomi; Ogane, Kana; Kawamura, Rieko; Kawamura, Toru; Takeuchi, Shinichi; Kamiyama, Yuki; Shiomi, Rie; Aoyagi, Ryutaro; Saito, Masaya; Kusano, Takeru; Nakaya, Nobuaki; Ka... Journal: Journal of infection and chemotherapy Issue: Volume 29:Issue 6(2023) Page Start: 586 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis. Issue 11 (26th September 2020) Authors: Uchida, Yoshihito; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Inao, Mie; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 11(2020) Page Start: 1264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis. Issue 12 (21st September 2020) Authors: Uchida, Yoshihito; Inao, Mie; Tsuji, Shohei; Uemura, Hayato; Kouyama, Jun‐ichi; Naiki, Kayoko; Sugawara, Kayoko; Nakao, Masamitsu; Nakayama, Nobuaki; Imai, Yukinori; Tomiya, Tomoaki; Mochida, Satoshi Journal: Hepatology research Issue: Volume 50:Issue 12(2020) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗